January 18, 2017
FDA OK’s Hikma’s US subsidiary’s narcolepsy drug
Hikma Pharmaceuticals’s US subsidiary Roxane Laboratories has received an approval from the US Food and Drug Administration for its Sodium…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
January 18, 2017
MDxHealth’s prostate cancer drug gets positive medical policy from Horizon BCBS
Horizon Blue Cross Blue Shield (Horizon BCBS) of New Jersey has issued a positive medical policy for the MDxHealth’s ConfirmMDx for Prostate Cancer test.
January 18, 2017
Christina Wood joins OptiBiotix Health as Sales and Marketing Director
OptiBiotix Health, a life sciences business developing compounds to tackle obesity, highcholesterol, diabetes and skin care, has appointed Christina Wood as Sales and Marketing Director.
January 18, 2017
Galapagos appoints Chief Medical Officer
Galapagos has appointed Dr. Walid Abi-Saab as a Chief Medical Officer (CMO), who came from Shire Pharmaceuticals, beginning on March 1, 2017.
January 18, 2017
EC’s approval for Sanofi’s Suliqua triggers $10 million payment to Zealand Pharma
Zealand Pharma has announced a $10 million milestone payment following Sanofi’s announcement of European Commission marketing authorization in Europe for…
January 18, 2017
Motif Bio grantes 1,500,000 options to purchase ordinary shares
Motif Bio, the clinical stage biopharmaceutical company specialising in developing novel antibiotics, has granted a total of 1,500,000 options to…
January 18, 2017
Ablynx issues additional common shares as result of warrant exercise
Ablynx has issued additional 154,342 common shares in exchange for EUR1,011,939.05 as the result of the exercise of warrants.
January 18, 2017
Erytech to presents new preclinical data on ERY-MET at the 2017 ASCO GI Symposium
Erytech Pharma’s new data supporting the second company’s product candidate ERY-MET will be presented at the 2017 Gastrointestinal Cancers Symposium…
January 17, 2017
Sanofi’s new insuline combination of Saliqua cleared for Europe
The European Commission has cleared Sanofi’s Suliqua in combination with metformin, type 2 diabetes treatment, for European adult patients.
January 17, 2017
Biogen settles to pay Danish Forward $1.25 bilion
Danish biopharmaceutical company, Forward Pharma, has entered a deal with Biogen and certain other parties, regarding a Settlement and License Agreement.